SEC Company Response from TECOGEN INC. (TGEN) (CIK 0001537435) (TGEN) — Dec 4, 2014
TECOGEN INC. (TGEN) (CIK 0001537435)
Date: Dec. 4, 2014 · CIK: 0001537435 · Accession: 0001537435-14-000100
AI Filing Summary & Sentiment
File numbers found in text: 333-199634
Referenced dates: December 1, 2014
Show Raw Text
CORRESP 1 filename1.htm TGN 2014 12 04 Corres - S-3 Comment Ltr ` December 4, 2014 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Jay Ingram, Legal Branch Chief Kamyar Daneshvar, Staff Attorney Re: Tecogen Inc. Registration Statement on Form S-3 Originally Filed October 28, 2014 Amendment No. 1 Filed November 26, 2014 File No. 333-199634 Dear Staff: We are submitting this letter on behalf of Tecogen Inc (the “Company” or “TGEN”) in response to comments from the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) received by electronic mail dated December 1, 2014 relating to the Company’s Amended Registration Statement on Form S-3 (File No. 333-199634) filed with the Commission on November 26, 2014 (“ Amended Registration Statement No. 1”). The numbered paragraphs below correspond to the numbered comments in the Staff’s letter and the Staff’s comments are presented in bold. General 1. Please amend your filing to include currently-dated signatures and an updated auditor’s consent. We have updated the signature dates. In order negate the necessity of an updated auditor's consent, we have deleted Part I. These change will be reflected in our amendment to Amended Registration Statement No 1. In addition, there have been no material changes in the Company's financial statements since October 28, 2014, the date that the original version of the aforementioned Form S-3 was filed. * * * In connection with responding to the Staff's comments, the Company hereby acknowledge and shall state in any future request for acceleration: • should the Commission or the Staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; • the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and • the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We appreciate your comments and welcome the opportunity to discuss with you our responses provided above. Please call me at (781) 466-6403 or our attorney, Edwin Miller of Sullivan & Worcester LLP in Boston, at (617) 338-2447 if you have any questions or require additional information.Sincerely, TECOGEN INC. By: /s/ David A. Garrison David A. Garrison Chief Financial Officer